These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 10961174)

  • 21. Comparison of monoclonal antibodies AUA1 and BER EP4 with anti-CEA for detecting carcinoma cells in serous effusions and distinguishing them from mesothelial cells.
    Robinson RJ; Royston D
    Cytopathology; 1993; 4(5):267-71. PubMed ID: 8274664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ber-EP4 staining in effusion cytology: A potential source of false positives.
    Díaz Del Arco C; Saiz-Pardo Sanz M; Ortega Medina L; Fernández Aceñero MJ
    Rev Esp Patol; 2021; 54(2):114-122. PubMed ID: 33726887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological screening for tumor cells in serous body fluids has added value with the CELL-DYN Sapphire.
    Keuren JF; Hoffmann JJ; Leers MP
    Clin Chem Lab Med; 2014 Feb; 52(2):253-8. PubMed ID: 24096441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
    Kundu R; Handa U; Mohan H
    Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunocytochemical staining of serous effusions: an additional method in the routine cytology practice?
    Lidang Jensen M; Johansen P
    Cytopathology; 1994 Apr; 5(2):93-103. PubMed ID: 8038428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: Special emphasis in atypical cytology.
    Sahu S; Gupta P; Susheilia S; Gautam U; Dey P
    Cytopathology; 2021 Mar; 32(2):169-179. PubMed ID: 33040400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology. II. Diagnostic accuracy in equivocal smears.
    Motherby H; Friedrichs N; Kube M; Nadjari B; Knops K; Donner A; Baschiera B; Dalquen P; Böcking A
    Anal Cell Pathol; 1999; 19(2):59-66. PubMed ID: 10746435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of flow cytometric analysis of serous effusions in the diagnosis of hematopoietic neoplasms in patients with prior hematopoietic malignancies.
    Iqbal J; Liu T; Mapow B; Swami VK; Hou JS
    Anal Quant Cytol Histol; 2010 Jun; 32(3):161-5. PubMed ID: 20701070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis.
    Selvaggi SM
    Diagn Cytopathol; 2003 Jun; 28(6):335-41. PubMed ID: 12768641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric identification of cancer cells in effusions with Ca1 monoclonal antibody.
    Czerniak B; Papenhausen PR; Herz F; Koss LG
    Cancer; 1985 Jun; 55(12):2783-8. PubMed ID: 3888371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings.
    Chhieng DC; Yee H; Cangiarella JF; Symmans WF; Cohen JM
    Cancer; 2000 Oct; 90(5):299-306. PubMed ID: 11038427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1.
    Bailey ME; Brown RW; Mody DR; Cagle P; Ramzy I
    Acta Cytol; 1996; 40(6):1212-6. PubMed ID: 8960030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The application of flow cytometric DNA analysis in detecting the presence of malignant cells in ovarian carcinoma peritoneal fluids.
    Kehoe S; Ward K; Luesley D; Chan KK
    Br J Obstet Gynaecol; 1995 Aug; 102(8):656-9. PubMed ID: 7654646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology.
    Ang PP; Tan GC; Karim N; Wong YP
    Acta Cytol; 2020; 64(3):248-255. PubMed ID: 31352449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of molecular genetics to the diagnosis of lymphoid-rich effusions: study of 95 cases with concomitant immunophenotyping.
    Mihaescu A; Gebhard S; Chaubert P; Rochat MC; Braunschweig R; Bosman FT; Delacrétaz F; Benhattar J
    Diagn Cytopathol; 2002 Aug; 27(2):90-5. PubMed ID: 12203875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases.
    Diaz-Arias AA; Loy TS; Bickel JT; Chapman RK
    Diagn Cytopathol; 1993 Oct; 9(5):516-21. PubMed ID: 8287759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The utility of claudin-4 versus MOC-31 and Ber-EP4 in the diagnosis of metastatic carcinoma in cytology specimens.
    Najjar S; Gan Q; Stewart J; Sneige N
    Cancer Cytopathol; 2023 Apr; 131(4):245-253. PubMed ID: 36522809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of adenocarcinoma in peritoneal washings by staining with monoclonal antibody B72.3.
    Szpak CA; Soper JT; Thor A; Schlom J; Johnston WW
    Acta Cytol; 1989; 33(2):205-14. PubMed ID: 2648721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.